JT001 is a potent and selective orally active inhibitor of NLRP3, targeting the NLRP3 inflammasome. By inhibiting the assembly of the inflammasome, JT001 effectively reduces cytokine release and prevents pyroptosis, allowing for potential therapeutic implications. This compound is valuable for research applications focusing on nonalcoholic steatohepatitis and liver fibrosis.
JT001 is a potent and selective orally active inhibitor of NLRP3, targeting the NLRP3 inflammasome. By inhibiting the assembly of the inflammasome, JT001 effectively reduces cytokine release and prevents pyroptosis, allowing for potential therapeutic implications. This compound is valuable for research applications focusing on nonalcoholic steatohepatitis and liver fibrosis.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
